Money
Cancer Vaccine Diagnostics as a New Investment Frontier
Personalized cancer vaccines from Moderna and Merck have boosted drugmakers' market value by over $50 billion, opening new investment paths in genomic sequencing diagnostics.
September 8, 2026, 04:49 AM·BeInCrypto